Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biodesix, Inc. - Common Stock (NQ: BDSX )

1.490 -0.040 (-2.61%)
Streaming Delayed Price Updated: 12:38 PM EST, Jan 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million
From Biodesix, Inc.
Via Business Wire
Biodesix Presents New Data from the INSIGHT Study at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Biodesix, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Biodesix: Q2 Earnings Insights
  Biodesix (NASDAQ:BDSX) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Biodesix Q3 Earnings
Biodesix (NASDAQ:BDSX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Biodesix missed estimated earnings... 
Via Benzinga
Biodesix Announces Third Quarter 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022
From Biodesix, Inc.
Via Business Wire
Biodesix Awarded U.S. Federal Supply Schedule Contract for Its Comprehensive Lung Cancer Diagnostic Testing Solutions
From Biodesix, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Imara (NASDAQ:IMRA) stock moved upwards by 37.2% to $3.54 during Friday's pre-market session. The market value of their outstanding shares is at $93.0 million. 
Via Benzinga
Biodesix to Present Data at the CHEST 2022 Annual Meeting Demonstrating High Sensitivity of the Nodify XL2® Blood-Based Lung Nodule Test in Various Patient Populations, Including Individuals Participating in Lung Cancer Screening Programs
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Preliminary Revenue for Third Quarter 2022
From Biodesix, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're taking a look at the biggest pre-market stock movers traders need to know about on Thursday morning! 
Via InvestorPlace
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash. 
Via Benzinga
Biodesix to Participate in Two Upcoming Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
Looking Into Biodesix's Return On Capital Employed
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q2 sales of $10.95 million. Earnings fell to a loss of $15.82 million, resulting in a 1.53% decrease from last quarter. 
Via Benzinga
Biodesix Named a Top 100 Healthcare Technology Company of 2022
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Second Quarter 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. 
Via Benzinga
Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022
From Biodesix, Inc.
Via Business Wire
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
Via Benzinga
Looking Into Biodesix's Return On Capital Employed
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q1 sales of $6.55 million. Earnings fell to a loss of $15.59 million, resulting in a 17.35% decrease from last quarter. 
Via Benzinga
Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million. 
Via Benzinga
Biodesix Announces Research Agreement with Top US Cancer Center
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the H.C. Wainwright Global Investment Conference
From Biodesix, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.